These pages contain information on
- the quarterly notifications for generic substitution and the reference price system
- the notification of prices to the Pharmaceutical Database
Pharmaceutical companies must report the prices for products that are included in generic substitution and in the reference price system to Kela 4 times a year. The quick guide gives a clear overview of the price notification procedure.